| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |